0.3(top 100%)
impact factor
212(top 50%)
papers
195(top 50%)
citations
5(top 50%)
h-index
0.3(top 100%)
extended IF
249
all documents
225
doc citations
9(top 50%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | Criteria for Assessment of Cognitive Impairment in Clinical Trials | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 21 |
| 2 | Dose Selection in Preclinical Studies: Cross-Species Dose Conversion | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 16 |
| 3 | Current Requirements for and Approaches to Dosing in Animal Studies | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 8 |
| 4 | CURRENT REQUIREMENTS FOR THE QUALITY OF HERBAL MEDICINAL PRODUCTS | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 8 |
| 5 | PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 5 |
| 6 | Quality Standards of Preclinical Pharmacological Studies | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 5 |
| 7 | Comparative Analysis of Heavy Metal and Arsenic Content in Various Herbal Dosage Forms Marketed in Russia | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 5 |
| 8 | PRINCIPLES OF STATISTICAL EVALUATION OF BIOEQUIVALENCE STUDIES IN THE CONTEXT OF CURRENT REGULATORY REQUIREMENTS AND LEGAL ACTS | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 5 |
| 9 | Evaluation of Coenzyme Q10 Redox Status as a Biomarker of Oxidative Stress | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 5 |
| 10 | The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1) | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 4 |
| 11 | Problems of Establishing Limits for Arsenic Content in Brown Algae and Brown Algae-Containing Medicinal Products | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 4 |
| 12 | Experimental Cell Line Models for Nephrotoxicity Screening | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 3 |
| 13 | GOOD DISTRIBUTION PRACTICE: MODERNISATION OF THE MEDICINES DISTRIBUTION SYSTEM IN RUSSIA | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 3 |
| 14 | THE USE OF A CHROMATOGRAPHIC COLUMN PACKED WITH AMIDE SORBENT FOR THE ANALYSIS OF PARABENS | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 3 |
| 15 | Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part I: Haematological Studies) | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 3 |
| 16 | Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies) | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 3 |
| 17 | Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 3 |
| 18 | Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 3 |
| 19 | Comparison of the Nomenclatures of Herbal Substances Used in the Russian and Foreign Pharmacopoeial Texts | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 3 |
| 20 | Analysis of the Medicinal Products for Human Use Authorised in the Russian Federation | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 3 |
| 21 | Determination of Heavy Metals, Arsenic, and Aluminum Content in Pumpkin Seed Herbal Substance and Native Products, by Inductively Coupled Plasma Mass Spectrometry | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 3 |
| 22 | Relevant Aspects of Standardisation of Plant Raw Materials and Herbal Medicinal Products Containing Phenolic Compounds | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 3 |
| 23 | Analysis of the Main Changes in Assessment and Approval of Medicines for Human Use in the Eurasian Economic Union | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 3 |
| 24 | Limitations of NIR Spectrometry as an Identification Test for Active Ingredients in Medicinal Products | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 2 |
| 25 | Planning a Clinical Development Programme for Medicines for Bronchial Asthma | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 2 |
| 26 | Determination of Anthracene Derivatives in Herbal Medicines | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 2 |
| 27 | CREATION OF AN INFORMATION SYSTEM FOR MANAGING THE ACTIVITIES OF TESTING LABORATORIES OF AN EXPERT INSTITUTION IN THE SPHERE OF MEDICINAL PRODUCTS CIRCULATION | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 2 |
| 28 | ELIMINATION OF FALSE RESULTS OF MEDICINES MICROBIOLOGICAL TESTING | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 2 |
| 29 | The main issues of quality assurance of radiopharmaceuticals | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 30 | The Problem of Dynamic Process Manifestation in Identification of Organic Compounds by NMR Spectroscopy | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 2 |
| 31 | EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 2 |
| 32 | X-RAY POWDER DIFFRACTION IN QUALITY CONTROL OF MEDICINES | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 2 |
| 33 | Development of Identification Test Methods for Triptorelin Acetate and Goserelin Acetate Substances using NMR spectroscopy | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 34 | Post-approval Variations to Dossiers for Vaccines: Analysis of Regulatory and Methodological Approaches Used in the Russian Federation and Abroad | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 35 | Conceptualisation of an Information Analytical Database of Reference Standards | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 36 | Assessment of the Feasibility of Therapeutic Equivalence Studies | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 37 | Validation of Enzyme Immunoassay for Preclinical Pharmacokinetic Trials of Rituximab | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 38 | Modern Approaches to Determination of the Biological Activity of Insulin and its | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 39 | Applicability of Capillary Gas-Liquid Chromatography for Determination of Parabens in Pharmaceutical Analysis | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2019 | 2 |
| 40 | Preclinical in vivo Neurotoxicity Studies of Drug Candidates | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2020 | 2 |
| 41 | Relevant Aspects of Drug Genetic Toxicology | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 2 |
| 42 | Quantitative clinical pharmacology and patient-centered healthcare technologies: perspectives 2030 | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2022 | 2 |
| 43 | Liposomes as Drug Carriers: Classification, Preparation Methods, and Medicinal Use | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2023 | 2 |
| 44 | Comparison of Approaches to Stability Testing of Medicines in the Russian Federation and the Eurasian Economic Union | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 1 |
| 45 | Use of Biomarkers in Pharmacokinetics Studies of Medicinal Products of Natural Origin | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 1 |
| 46 | Stability of Ready-to-Use and Laboratory-Prepared Culture Media | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 1 |
| 47 | Determination of Arbutin in Herbal Medicinal Products | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 1 |
| 48 | ASPECTS OF MEDICINES QUALITY EVALUATION BY ELECTRICAL SENSING ZONE METHOD | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 1 |
| 49 | MODERN ASPECTS OF HOMEOPATHIC MEDICINES STANDARDISATION | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2018 | 1 |
| 50 | Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China) | The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products | 2021 | 1 |